Background Lung transplantation (LUTX) is often complicated by primary graft dysfunction
(PGD). Plasma biomarkers hold potential for PGD phenotyping and targeted therapy. This …

Janus kinase (JAK) inhibitors are a novel group of immunosuppressive drugs approved to
treat certain rheumatic and allergic disorders; however, their efficacy in the regulation of …

Background: Chronic obstructive pulmonary disease (COPD) is characterized by
progressive obstruction of airways due to chronic inflammation. Both genetic and …

Hypogonadism is understudied in men requiring solid organ transplants, particularly among
lung transplant recipients. Improvement in serum testosterone levels has been reported in …

Purpose Acute rejection is a frequent complication among lung transplant recipients and
poses substantial therapeutic challenges. 15-hydroxyprostaglandin dehydrogenase (15 …

Introduction The postoperative hemodynamic management after lung transplant (LUTX) is
guided by limited evidence. We aimed to describe and evaluate risk factors and outcomes of …

Until now, the ability to predict or retard immune-mediated rejection events after lung
transplantation is still limited due to the lack of specific biomarkers. The pressing need …

Introduction Cold static donor lung preservation at 10° C appears to be a promising method
to safely extend the cold ischemic time (CIT) and improve lung transplant (LTx) logistics …

The key to treat cancer is early detection. This study has reviewed the fractal image analysis
technique for cancer cell detection. Typical abnormalities in cancer cells include …

The information shows that there were 2.2 million new belongings of lung cancer in 2023. Its
quantity is still rising yearly. As a result, it has become an extremely significant issue how to …